The goal of this initiative is to support the identification, validation and manipulation of neural circuits that underlie cognitive, emotional, and social processes impacted in mental illnesses. The initiative is focused on probing psychiatrically relevant behavior through studies in non-human primates. This initiative is intended to complement existing NIMH-funded preclinical investigation of circuits which have often focused on smaller brains.
Source: nimh

The goal of this initiative is to support grant applications in two related but distinct areas. The first area involves developing and testing novel tools and methods of neuromodulation that go beyond the existing forms of neural stimulation. The second area involves the optimization of existing stimulation methods.
Source: nimh

The goal of the NCDDG Program is to advance the discovery, preclinical development, and early proof of concept testing in humans of new pharmacologic and neuromodulatory approaches to treat mental disorders, substance use disorders (SUDs), or alcohol addiction, and to develop novel ligands and circuit-engagement devices as tools to further characterize existing or to validate new drug/device targets.
Source: nimh

The purpose of the Conte Centers program is to support interdisciplinary teams of researchers engaged in novel, creative, and integrated experimental approaches to address high-risk, high-impact scientific questions in either basic neuroscience research or in translational research that will significantly advance the state of the science in brain and behavioral research to ultimately provide the foundation for understanding mental disorders and/or transform the understanding and treatment of mental illnesses, as well as developing data and other research resources that are available to the scientific community to further advance research in this field.
Source: nimh

Principal Investigator and Chief of the Behavioral Endocrinology Branch, Dr. Peter Schmidt, Research Fellow Dr. Shau-Ming Wei, and Postdoctoral Fellow Dr. Kathy Reding, discuss the typical pubertal transition, how puberty affects brain development, what changes parents might expect in their children, and what NIMH hopes to learn from the research.
Source: nimh

On Tuesday, May 21, 2019, the Interagency Autism Coordinating Committee (IACC) Working Group will host a workshop to discuss mental health issues that affect people on the autism spectrum, including anxiety, depression, suicide, self-injurious and aggressive behavior, and mental health services.
Source: nimh

In this Director’s Message, Dr. Gordon discusses research-based advances in the understanding and treatment of depression.
Source: nimh

In recognition of National Children’s Mental Health Awareness Day, Dr. Peter Schmidt, Principal Investigator and Chief of the Behavioral Endocrinology Branch, and Postdoctoral Fellow, Dr. Kathy Reding, will join NIMH’s Facebook Live event to discuss how puberty affects brain development.
Source: nimh

This workshop is intended to foster discussion among experts in the field with the goal of identifying future research priorities in the area of child suicide risk.
Source: nimh

On May 2, 2019, Dr. Gregory Berns presents “Seven Years and One-Hundred MRI-Dogs: Awake Unrestrained fMRI in Dogs Reveals Common Neurobiology and Implications for Human Health and Disease” as part of the NIMH Director’s Innovation Speaker Series.
Source: nimh